Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant [Phase 1]
Phase 1 clinical trial update evaluating the use of bortezomib in multiple myeloma patients who have undergone autologous peripheral blood s…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 study evaluating the combination of bortezomib, ascorbic acid, and melphalan in newly diagnosed multiple myeloma patients. The trial…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma [Phase 1, Phase 2]
This is a completed Phase 1/2 clinical trial evaluating fluphenazine in patients with refractory advanced multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1]
Phase 1 clinical trial update reporting treated T cells followed by a stem cell transplant in patients with multiple myeloma. The study stat…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating Samarium-153 in combination with Bortezomib in patients with relapsed or refractory multiple myeloma; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma [Phase 3]
Clinical trial update for a Phase 3 study evaluating chemotherapy plus steroid therapy in patients with multiple myeloma. The current status…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study evaluating Human Immune Globulin for AL amyloidosis-related heart dysfunction. Results w…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated a triplet regimen of bortezomib, liposomal doxorubicin, and thalidomide as first-line therapy for patients with…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy [Phase 3]
This Phase 3 clinical trial compares high-dose melphalan with a second stem cell transplant to low-dose cyclophosphamide for patients with r…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma [Phase 2]
This entry describes a Phase 2 clinical trial evaluating high-dose chemotherapy followed by stem cell transplantation in patients with newly…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Combination Chemotherapy in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial of combination chemotherapy in patients with multiple myeloma and plasma cell neoplasm has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma [Phase 3]
Phase 3 trial S0232 assessed dexamethasone with or without lenalidomide in previously untreated Stage I–III multiple myeloma. The study resu…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update on SU5416 for patients with refractory or relapsed multiple myeloma, with the study status noted as …
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial of isotretinoin plus dexamethasone for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating interferon alfa after chemotherapy and peripheral stem cell transplantation in patients with Stage III or …
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer [Phase 1]
A Phase 1 clinical trial update reports completion of arsenic trioxide in patients with advanced hematologic cancers, including leukemia and…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update evaluating bevacizumab with or without thalidomide in relapsed or refractory multiple myeloma; the s…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Interleukin-12 in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating interleukin-12 in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma [Phase 2]
Phase 2 trial update evaluating melphalan and filgrastim to stimulate peripheral stem cell collection in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: PS-341 in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial update of PS-341 (bortezomib) in hematologic cancers; the study has completed and includes leukemia, lymphoma, multiple myelom…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma [Phase 3]
This is an update on a Phase 3 trial evaluating combination chemotherapy for stage II/III multiple myeloma that has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
Bryostatin-1 was studied in patients with relapsed multiple myeloma. The Phase 2 study has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan
This clinical trial update indicates the study NCT00602147, investigating genetic mutations related to mucositis in multiple myeloma patient…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated thalidomide, doxorubicin, and dexamethasone in patients with untreated stage II or stage III multiple myeloma, …
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of AE-941 for relapsed or refractory Multiple Myeloma has been completed, reported by AEterna Zentaris.